TNFSF14 and chronic graft versus host disease: There were no significant differences in the serum β2-MG, sVCAM-1, PF-4, and TNFSF-14 levels on day − 7 and day + 14 between the extensive chronic GVHD and no or limited chronic GVHD cases (Table 4).